Brief: OncoTherapy Science gets patent license
16/05/2016 09:38
May 16 (Reuters) - OncoTherapy Science Inc 4564.T :
* Says received a patent license in China
* Says the patent is for specific inhibitor of TOPK (T-LAK
cell-originated protein kinase), which being developed as an
anti-cancer agent
Source text in Japanes: https://goo.gl/CJOOPj
Further company Coverage: 4564.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging:
Beijing.HeadlineNews@thomsonreuters.com@reuters.net))
Keywords: ONCOTHERAPY SCIENCE/BRIEF